2024-10-17 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis

**Company Overview:** Thermo Fisher Scientific Inc. is a global leader in providing scientific research and analytical instruments, reagents, consumables, and software services for various industries. 

**1. Performance Comparison:**

* **Cumulative Return:** TMO: 243.13%, VOO (S&P 500): 135.94%
* **Outperformance:** TMO has outperformed the S&P 500 by **107.19%**.  This puts TMO in the **49.59th percentile** of its historical performance range relative to the S&P 500. 

**2. Recent Price Action:**

* **Closing Price:** $600.52
* **5-Day Moving Average:** $598.50
* **20-Day Moving Average:** $606.61
* **60-Day Moving Average:** $606.26

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 50.52, indicating neither overbought nor oversold conditions.
* **PPO (Percentage Price Oscillator):** -0.2, suggesting a slight bearish momentum.
* **Delta_Previous_Relative_Divergence:** -6.14, implying a recent short-term downward trend in relative performance.
* **Expected Return:** 13.27%, indicating potential for significant outperformance over the next five years, considering historical performance against the S&P 500.

**4. Recent Earnings and Outlook:**

| Date         | EPS  | Revenue           |
|--------------|------|-------------------|
| 2024-08-02  | 4.05 | $10.54 Billion    |
| 2024-05-03  | 3.47 | $10.35 Billion    |
| 2023-11-03  | 4.44 | $10.57 Billion    |
| 2023-08-04  | 3.53 | $10.69 Billion    |
| 2024-08-02  | 3.53 | $10.69 Billion    |

* The most recent earnings (2024-08-02) reported EPS of $4.05, exceeding analyst estimates by a significant margin. This strong performance showcases the company's continued resilience and growth. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** Thermo Fisher Scientific continues to be a strong performer, driven by its robust growth in life sciences and diagnostics, along with its ongoing investment in R&D.
* **Analyst Opinions:**  Most analysts maintain a bullish outlook on TMO, citing its strong fundamentals, diversified business model, and potential for further expansion.
* **Performance Highlights:** TMO has consistently delivered strong earnings and revenue growth, exceeding market expectations.  

**6. Overall Analysis:**

* **Strong Historical Outperformance:** TMO has significantly outperformed the S&P 500, suggesting a positive long-term growth trajectory.
* **Solid Fundamental Performance:** The company demonstrates consistent growth in earnings and revenue, supported by its strong position in key industries.
* **Positive Market Sentiment:** Analysts are largely optimistic about TMO's future prospects.
* **Mixed Short-Term Indicators:** While some technical indicators suggest a slight bearish bias, the overall market outlook and the company's fundamentals paint a bullish picture.

**7. Conclusion:**

Thermo Fisher Scientific (TMO) remains a compelling investment option with a strong track record of performance and a bright future outlook. The company's consistent growth, positive market sentiment, and strong fundamentals make it an attractive choice for investors seeking long-term capital appreciation. However, it is crucial to monitor market conditions and technical indicators closely for potential short-term fluctuations. 
